SITAGLIPTIN PHOSPHATE
Substance profile for UNII TS63EW8X6F, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 11591741Substance Identity#
- UNII
- TS63EW8X6F
- Preferred term
- SITAGLIPTIN PHOSPHATE
- Registry number
- 654671-77-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C16H15F6N5O.H2O.H3O4P
Structure render from PubChem CID 11591741Chemical And Database Identifiers#
- InChIKey
- GQPYTJVDPQTBQC-KLQYNRQASA-N
- SMILES
- O.OP(O)(O)=O.N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC3=C(F)C=C(F)C(F)=C3
- RxCUI
- 621590
- PubChem
- 11591741
- NCIt
- C73811
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) Tablets Initial U.S. Approval: 2006 | 1 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initial U.S. Approval: 2006 | 3 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3631 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3630 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | 45 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | 33 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.] | 16 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH] | 11 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH] | 3 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH] | 2 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH] | 2 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 | |
| SITAGLIPTIN PHOSPHATE | ACTIVE INGREDIENT | TS63EW8X6F | JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 | |